| 1 |
Placental transfer and pharmacokinetics of a single oral dose of [14C]p-nitrophenol in rats  |
미소장 |
| 2 |
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.  |
미소장 |
| 3 |
Deve10p-mental toxicity of DW-116, a new fluoroquinolone antibac-terial agenl, in rats. |
미소장 |
| 4 |
Embryotoxic Effects of SKI 2053R, A New Potential Anticancer Agent, in Rats  |
미소장 |
| 5 |
Antimicrobial Prophylaxis with Ceftriaxone in Renal Transplantation  |
미소장 |
| 6 |
The cytotoxic effects of fleroxacin and ciprofloxacin on transitional cell carcinoma in Vitro  |
미소장 |
| 7 |
Biopharmaceutcs and Clinical Pharma-cokinetics |
미소장 |
| 8 |
Chemistry and mechanism of action of the quinolone antibacterials |
미소장 |
| 9 |
In vitro and in vivo activity of DW-116, a new quinolone antibiotic. 35th Intersci |
미소장 |
| 10 |
In vitro and in vivo antibacterial activity of DW-116, a new quinolone antibio-tic. |
미소장 |
| 11 |
Fluoroquinolone antimicrobial agents.  |
미소장 |
| 12 |
Toxicokinetics: its significance and practical problems. |
미소장 |
| 13 |
Embryo lethality and teratogenicity of a new fluoroquinolone antibactenal DW-116 in rats. |
미소장 |
| 14 |
Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy  |
미소장 |
| 15 |
Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.  |
미소장 |
| 16 |
Pharmacokinetic study of a new quinolone |
미소장 |
| 17 |
1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents  |
미소장 |
| 18 |
Reproductive and developmental toxicity studies of Pruli-floxacin (NM441) (3): a teratogenicity study in rabbits by oral administration. |
미소장 |
| 19 |
Quinolone antimicrobial agents.  |
미소장 |
| 20 |
Metabolic disposition of the new fluoro-quinolone antibacterial agent DW116 in rats. |
미소장 |
| 21 |
Assessment of the Developmental Toxicity and Placental Transfer of 1,2-Diethylbenzene in Rats |
미소장 |
| 22 |
Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development  |
미소장 |
| 23 |
Adverse effects of fluoroqui-nolones. |
미소장 |
| 24 |
Overview of toxicokinetics. |
미소장 |
| 25 |
Toxicity of quinulones |
미소장 |
| 26 |
Teratological study of fleroxacin in rabbits. |
미소장 |
| 27 |
Toxicity of quinolone antimicrobial agents. |
미소장 |
| 28 |
Reproductive toxicity of ofloxacin.  |
미소장 |
| 29 |
Teratological study of oral administration of NY-198 in rabbits. |
미소장 |
| 30 |
The Fluoroquinolones  |
미소장 |
| 31 |
Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits.  |
미소장 |
| 32 |
Overview of fluoroquinolone safety  |
미소장 |
| 33 |
Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.  |
미소장 |
| 34 |
Novel quinolone carboxylic acid derivatives |
미소장 |
| 35 |
Pharmacokinetics of 1‐(5‐fluoro‐2‐pyridyl)‐6‐fluoro‐7‐(4‐methyl‐1‐piperazinyl)‐1,4‐dihydro‐4‐oxoquinolone‐3‐carboxylic acid hydrochloride (DW‐116), a new quinolone antibiotic in rats  |
미소장 |